Image
Explore the key conclusions around aiming for higher treatment targets, discussed at the UCB-sponsored Satellite Symposium presented at EULAR 2023.
Back to top
Prof Lluís Puig
Director of Dermatology
Professor Lluís Puig is Director of Dermatology at the Hospital de la Santa Creu i Sant Pau, Barcelona, Spain, and Professor of Dermatology at the University of Barcelona, Spain.
For over 15 years, Professor Puig’s clinical research has focused on the treatment of psoriasis with biological agents. He has worked on over 85 clinical trials and research projects, primarily as the principal investigator.
Professor Puig also serves on several editorial boards and has published over 300 papers in journals such as The New England Journal of Medicine, Journal of the European Academy of Dermatology and Venereology, and British Journal of Dermatology.
He is a member of multiple national and international scientific societies, has been a member of the board of directors of the European Academy of Dermatology and Venereology (EADV), and is co-Chair of the Psoriasis Task Force of the EADV, Member of the GRAPPA Education and Steering Committees, and Board Member of the International Psoriasis Council.
0 resources
You are currently seeing only Rheumatology content
Video3 minutes watch
Watch Prof Lars Erik Kristensen and Prof Frank Behrens discuss how MDA is a realistic treatment target in clinical practice and the barriers to achieving it for...
EU-DA-2400669
Video2 minutes watch
Treatment for PsA should target a broad range of musculoskeletal and extra-articular manifestations.1 Listen to Assoc. Prof Philipp Sewerin explain how MDA can...
EU-DA-2400668
Video2 minutes watch
axSpA is a complex disease with a significant burden on many aspects of daily life.1,2 Dive into the importance of ASAS40 for your patients with Dr Fabian Proft.
EU-DA-2400666
Video1 minute watch
Watch Prof Robert Landewé discuss the importance of using ASDAS <2.1 as a treatment target for patients with axSpA.
EU-DA-2400662
Article3 minutes read
Read our key takeaways from the 2022 ASAS-EULAR recommendations for the management of axSpA, presented as part of Dr Sofia Ramiro's workshop at UCB Summit 2023.
EU-DA-2400660